Johnson Controls is a worldwide company founded by Robert Johnson. He was an American industrialist and entrepreneur. Mr. Johnson drew inspiration from creating a scientific appreciation of effective sanitation and germ models. His primary objective was to create an easy antiseptic surgical procedure. The Johnson Controls Company diversified its commercial activities to include medical devices, pharmaceuticals, and packaged commodities. The company was able to oversee its expansion due to several studies and approaches. It has become one of the major healthcare companies across the globe due to its brand name of Johnson & Johnson (J&J). The business runs operations through three commercial portions. The first segment of the company deals with pharmaceuticals. The organization’s pharmaceutical commodities comprise of family planning, cardiovascular, nervous system and mental disorders, immunotherapy, gastroenterology, oncology, pain management, and allergy control drugs. This segment creates about 48% of the company’s revenue and about 59% of the J&J Company’s operating financial gains. The second segment deals with medical devices and diagnostics. It includes patient care and surgical devices and equipment, coronary stents, diagnostic products, contact lenses, and joint replacements. This section accounts for about 37% of the organization’s revenue. It is also accountable for about 32% of the J&J Company’s operating finances. The third segment comprises of consumer products. This component accounts for about 18% of the company’s revenue. It also creates about 12% of the operating profits for the business. The organization has survived many historical episodes to develop a formidable commercial brand in the healthcare industry. It has achieved this aspect through effective strategic planning and efficient client care. This paper reviews the 2012 financial results of the Johnson Controls Company and the economic outlook of the firm. The study provides a suggestion of a methodology of supplementing the ancient methods of assessment of the capital investments of the company. It also discusses the potential effects of inflation on deliberate capital ventures in China and likely methods of providing an objective evaluation of the investments. The report discusses the potential modifications of assessing the schemes to increase internal capacity in North America and expansion schemes in the global market. It also reviews how these facts may affect the company’s prospects for growth. The study examines the merits of applying sensitivity analysis in assessing the programs of Johnson Controls and how this design can provide a competitive edge for the company over its business rivals (Weygandt et al., 2012). This paper makes an analysis of the documentation of the company’s profit margins and sales for the fiscal year of 2012. The projections indicate that the company had total revenues of $ 10.8 billion during the fourth quarter of the year 2011. The Johnson Controls Company had envisaged a rise in automotive production, in Northern America and China in its 2012 ventures (Schmidt, 2008). The company had also estimated an increase in financial gains with about 7% in the year 2012. Th